GlaxoSmithKline Stock | GSK.L | GB0009252882 | 940561

Date	GlaxoSmithKline Price
9/6/2024	16.52 undefined
9/5/2024	16.39 undefined
9/4/2024	16.64 undefined
9/3/2024	16.55 undefined
9/2/2024	16.51 undefined
8/30/2024	16.57 undefined
8/29/2024	16.52 undefined
8/28/2024	16.52 undefined
8/27/2024	16.18 undefined
8/23/2024	16.03 undefined
8/22/2024	15.97 undefined
8/21/2024	15.96 undefined
8/20/2024	15.92 undefined
8/19/2024	15.99 undefined
8/16/2024	15.91 undefined
8/15/2024	15.96 undefined
8/14/2024	15.98 undefined
8/13/2024	15.93 undefined
8/12/2024	15.72 undefined

Date	GlaxoSmithKline Revenue	GlaxoSmithKline EBIT	GlaxoSmithKline Net Income
2029e	39.33 B undefined	0 undefined	8.72 B undefined
2028e	39.05 B undefined	12.46 B undefined	9.25 B undefined
2027e	38.64 B undefined	12.35 B undefined	9.08 B undefined
2026e	36.48 B undefined	10.98 B undefined	8.2 B undefined
2025e	34.49 B undefined	9.9 B undefined	7.38 B undefined
2024e	32.61 B undefined	8.84 B undefined	6.71 B undefined
2023	30.33 B undefined	8.3 B undefined	4.93 B undefined
2022	29.32 B undefined	8.4 B undefined	14.96 B undefined
2021	24.7 B undefined	5.75 B undefined	4.39 B undefined
2020	24.35 B undefined	5.99 B undefined	5.75 B undefined
2019	33.75 B undefined	8.88 B undefined	4.65 B undefined
2018	30.82 B undefined	8.36 B undefined	3.62 B undefined
2017	30.19 B undefined	7.99 B undefined	1.53 B undefined
2016	27.89 B undefined	7.04 B undefined	912 M undefined
2015	23.92 B undefined	4.97 B undefined	8.42 B undefined
2014	23.01 B undefined	5.48 B undefined	2.76 B undefined
2013	26.51 B undefined	7.2 B undefined	5.44 B undefined
2012	26.43 B undefined	7.88 B undefined	4.57 B undefined
2011	27.39 B undefined	8.18 B undefined	5.26 B undefined
2010	28.39 B undefined	4.96 B undefined	1.63 B undefined
2009	28.37 B undefined	8.82 B undefined	5.53 B undefined
2008	24.35 B undefined	8.04 B undefined	4.6 B undefined
2007	22.72 B undefined	7.36 B undefined	5.21 B undefined
2006	23.23 B undefined	7.62 B undefined	5.39 B undefined
2005	21.66 B undefined	6.6 B undefined	4.69 B undefined
2004	20.36 B undefined	6.09 B undefined	4.3 B undefined

	Revenue	EBIT	Net Income
2004	20.36 B GBP	6.09 B GBP	4.3 B GBP
2005	21.66 B GBP	6.6 B GBP	4.69 B GBP
2006	23.23 B GBP	7.62 B GBP	5.39 B GBP
2007	22.72 B GBP	7.36 B GBP	5.21 B GBP
2008	24.35 B GBP	8.04 B GBP	4.6 B GBP
2009	28.37 B GBP	8.82 B GBP	5.53 B GBP
2010	28.39 B GBP	4.96 B GBP	1.63 B GBP
2011	27.39 B GBP	8.18 B GBP	5.26 B GBP
2012	26.43 B GBP	7.88 B GBP	4.57 B GBP
2013	26.51 B GBP	7.2 B GBP	5.44 B GBP
2014	23.01 B GBP	5.48 B GBP	2.76 B GBP
2015	23.92 B GBP	4.97 B GBP	8.42 B GBP
2016	27.89 B GBP	7.04 B GBP	912 M GBP
2017	30.19 B GBP	7.99 B GBP	1.53 B GBP
2018	30.82 B GBP	8.36 B GBP	3.62 B GBP
2019	33.75 B GBP	8.88 B GBP	4.65 B GBP
2020	24.35 B GBP	5.99 B GBP	5.75 B GBP
2021	24.7 B GBP	5.75 B GBP	4.39 B GBP
2022	29.32 B GBP	8.4 B GBP	14.96 B GBP
2023	30.33 B GBP	8.3 B GBP	4.93 B GBP
2024e	32.61 B GBP	8.84 B GBP	6.71 B GBP
2025e	34.49 B GBP	9.9 B GBP	7.38 B GBP
2026e	36.48 B GBP	10.98 B GBP	8.2 B GBP
2027e	38.64 B GBP	12.35 B GBP	9.08 B GBP
2028e	39.05 B GBP	12.46 B GBP	9.25 B GBP
2029e	39.33 B GBP	0 GBP	8.72 B GBP

GlaxoSmithKline Gross margin	GlaxoSmithKline Profit margin	GlaxoSmithKline EBIT margin	GlaxoSmithKline Profit margin
2029e	72.42 %	0 %	22.18 %
2028e	72.42 %	31.9 %	23.7 %
2027e	72.42 %	31.96 %	23.51 %
2026e	72.42 %	30.1 %	22.47 %
2025e	72.42 %	28.71 %	21.41 %
2024e	72.42 %	27.1 %	20.57 %
2023	72.42 %	27.38 %	16.25 %
2022	71.13 %	28.63 %	51 %
2021	67.58 %	23.28 %	17.76 %
2020	69.94 %	24.61 %	23.61 %
2019	69.88 %	26.32 %	13.76 %
2018	68.94 %	27.13 %	11.75 %
2017	69.13 %	26.46 %	5.08 %
2016	68.09 %	25.26 %	3.27 %
2015	66.38 %	20.76 %	35.2 %
2014	69.41 %	23.82 %	11.98 %
2013	69.82 %	27.16 %	20.51 %
2012	71.79 %	29.82 %	17.27 %
2011	73.49 %	29.85 %	19.21 %
2010	73.92 %	17.46 %	5.76 %
2009	74.99 %	31.08 %	19.5 %
2008	76.28 %	33.01 %	18.9 %
2007	76.59 %	32.39 %	22.95 %
2006	78.43 %	32.83 %	23.2 %
2005	78.01 %	30.47 %	21.65 %
2004	78.83 %	29.91 %	21.13 %

	Gross margin	EBIT margin	Profit margin
2004	78.83 %	29.91 %	21.13 %
2005	78.01 %	30.47 %	21.65 %
2006	78.43 %	32.83 %	23.2 %
2007	76.59 %	32.39 %	22.95 %
2008	76.28 %	33.01 %	18.9 %
2009	74.99 %	31.08 %	19.5 %
2010	73.92 %	17.46 %	5.76 %
2011	73.49 %	29.85 %	19.21 %
2012	71.79 %	29.82 %	17.27 %
2013	69.82 %	27.16 %	20.51 %
2014	69.41 %	23.82 %	11.98 %
2015	66.38 %	20.76 %	35.2 %
2016	68.09 %	25.26 %	3.27 %
2017	69.13 %	26.46 %	5.08 %
2018	68.94 %	27.13 %	11.75 %
2019	69.88 %	26.32 %	13.76 %
2020	69.94 %	24.61 %	23.61 %
2021	67.58 %	23.28 %	17.76 %
2022	71.13 %	28.63 %	51 %
2023	72.42 %	27.38 %	16.25 %
2024e	72.42 %	27.1 %	20.57 %
2025e	72.42 %	28.71 %	21.41 %
2026e	72.42 %	30.1 %	22.47 %
2027e	72.42 %	31.96 %	23.51 %
2028e	72.42 %	31.9 %	23.7 %
2029e	72.42 %	0 %	22.18 %

Date	GlaxoSmithKline Sales per Share	GlaxoSmithKline EBIT per share	GlaxoSmithKline Earnings per Share
2029e	9.64 undefined	0 undefined	2.14 undefined
2028e	9.57 undefined	0 undefined	2.27 undefined
2027e	9.47 undefined	0 undefined	2.23 undefined
2026e	8.94 undefined	0 undefined	2.01 undefined
2025e	8.46 undefined	0 undefined	1.81 undefined
2024e	8 undefined	0 undefined	1.64 undefined
2023	7.38 undefined	2.02 undefined	1.2 undefined
2022	7.18 undefined	2.06 undefined	3.66 undefined
2021	6.09 undefined	1.42 undefined	1.08 undefined
2020	6.04 undefined	1.49 undefined	1.43 undefined
2019	8.41 undefined	2.21 undefined	1.16 undefined
2018	7.75 undefined	2.1 undefined	0.91 undefined
2017	7.64 undefined	2.02 undefined	0.39 undefined
2016	7.1 undefined	1.79 undefined	0.23 undefined
2015	4.89 undefined	1.02 undefined	1.72 undefined
2014	4.73 undefined	1.13 undefined	0.57 undefined
2013	5.39 undefined	1.46 undefined	1.11 undefined
2012	5.3 undefined	1.58 undefined	0.92 undefined
2011	5.37 undefined	1.6 undefined	1.03 undefined
2010	5.54 undefined	0.97 undefined	0.32 undefined
2009	5.55 undefined	1.73 undefined	1.08 undefined
2008	4.66 undefined	1.54 undefined	0.88 undefined
2007	4.08 undefined	1.32 undefined	0.94 undefined
2006	4.07 undefined	1.34 undefined	0.95 undefined
2005	3.79 undefined	1.15 undefined	0.82 undefined
2004	3.54 undefined	1.06 undefined	0.75 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	3.54 GBP	1.06 GBP	0.75 GBP
2005	3.79 GBP	1.15 GBP	0.82 GBP
2006	4.07 GBP	1.34 GBP	0.95 GBP
2007	4.08 GBP	1.32 GBP	0.94 GBP
2008	4.66 GBP	1.54 GBP	0.88 GBP
2009	5.55 GBP	1.73 GBP	1.08 GBP
2010	5.54 GBP	0.97 GBP	0.32 GBP
2011	5.37 GBP	1.6 GBP	1.03 GBP
2012	5.3 GBP	1.58 GBP	0.92 GBP
2013	5.39 GBP	1.46 GBP	1.11 GBP
2014	4.73 GBP	1.13 GBP	0.57 GBP
2015	4.89 GBP	1.02 GBP	1.72 GBP
2016	7.1 GBP	1.79 GBP	0.23 GBP
2017	7.64 GBP	2.02 GBP	0.39 GBP
2018	7.75 GBP	2.1 GBP	0.91 GBP
2019	8.41 GBP	2.21 GBP	1.16 GBP
2020	6.04 GBP	1.49 GBP	1.43 GBP
2021	6.09 GBP	1.42 GBP	1.08 GBP
2022	7.18 GBP	2.06 GBP	3.66 GBP
2023	7.38 GBP	2.02 GBP	1.2 GBP
2024e	8 GBP	0 GBP	1.64 GBP
2025e	8.46 GBP	0 GBP	1.81 GBP
2026e	8.94 GBP	0 GBP	2.01 GBP
2027e	9.47 GBP	0 GBP	2.23 GBP
2028e	9.57 GBP	0 GBP	2.27 GBP
2029e	9.64 GBP	0 GBP	2.14 GBP

	Number of stocks
2004	5.75 B Aktien
2005	5.72 B Aktien
2006	5.7 B Aktien
2007	5.57 B Aktien
2008	5.23 B Aktien
2009	5.11 B Aktien
2010	5.13 B Aktien
2011	5.1 B Aktien
2012	4.99 B Aktien
2013	4.92 B Aktien
2014	4.87 B Aktien
2015	4.89 B Aktien
2016	3.93 B Aktien
2017	3.95 B Aktien
2018	3.98 B Aktien
2019	4.01 B Aktien
2020	4.03 B Aktien
2021	4.05 B Aktien
2022	4.08 B Aktien
2023	4.11 B Aktien
2024e	4.11 B Aktien
2025e	4.11 B Aktien
2026e	4.11 B Aktien
2027e	4.11 B Aktien
2028e	4.11 B Aktien
2029e	4.11 B Aktien

Date	GlaxoSmithKline Dividend
2029e	1 undefined
2028e	1.01 undefined
2027e	1 undefined
2026e	0.99 undefined
2025e	1.04 undefined
2024e	0.97 undefined
2023	0.56 undefined
2022	0.67 undefined
2021	0.8 undefined
2020	0.8 undefined
2019	0.8 undefined
2018	0.8 undefined
2017	0.8 undefined
2016	0.82 undefined
2015	1.11 undefined
2014	1.11 undefined
2013	0.97 undefined
2012	0.96 undefined
2011	0.94 undefined
2010	0.84 undefined
2009	0.83 undefined
2008	0.78 undefined
2007	0.71 undefined
2006	0.67 undefined
2005	0.58 undefined
2004	0.61 undefined

	Dividend	Dividend (Estimate)
2004	0.61 GBP	0 GBP
2005	0.58 GBP	0 GBP
2006	0.67 GBP	0 GBP
2007	0.71 GBP	0 GBP
2008	0.78 GBP	0 GBP
2009	0.83 GBP	0 GBP
2010	0.84 GBP	0 GBP
2011	0.94 GBP	0 GBP
2012	0.96 GBP	0 GBP
2013	0.97 GBP	0 GBP
2014	1.11 GBP	0 GBP
2015	1.11 GBP	0 GBP
2016	0.82 GBP	0 GBP
2017	0.8 GBP	0 GBP
2018	0.8 GBP	0 GBP
2019	0.8 GBP	0 GBP
2020	0.8 GBP	0 GBP
2021	0.8 GBP	0 GBP
2022	0.67 GBP	0 GBP
2023	0.56 GBP	0 GBP
2024e	0 GBP	0.97 GBP
2025e	0 GBP	1.04 GBP
2026e	0 GBP	0.99 GBP
2027e	0 GBP	1 GBP
2028e	0 GBP	1.01 GBP
2029e	0 GBP	1 GBP

Date	GlaxoSmithKline Payout ratio
2029e	43.69 %
2028e	42.37 %
2027e	43.6 %
2026e	45.1 %
2025e	38.4 %
2024e	47.32 %
2023	49.57 %
2022	18.31 %
2021	74.07 %
2020	56.34 %
2019	69.11 %
2018	87.91 %
2017	210.53 %
2016	352.69 %
2015	64.49 %
2014	194.93 %
2013	87.34 %
2012	104.77 %
2011	91.69 %
2010	262.13 %
2009	77.15 %
2008	88.39 %
2007	75.36 %
2006	70.18 %
2005	71.15 %
2004	81.48 %

	Payout ratio
2004	81.48 %
2005	71.15 %
2006	70.18 %
2007	75.36 %
2008	88.39 %
2009	77.15 %
2010	262.13 %
2011	91.69 %
2012	104.77 %
2013	87.34 %
2014	194.93 %
2015	64.49 %
2016	352.69 %
2017	210.53 %
2018	87.91 %
2019	69.11 %
2020	56.34 %
2021	74.07 %
2022	18.31 %
2023	49.57 %
2024e	47.32 %
2025e	38.4 %
2026e	45.1 %
2027e	43.6 %
2028e	42.37 %
2029e	43.69 %

Date	EPS Estimate	EPS Actual	Quarterly report
6/30/2024	0.39	0.43 (11.25 %)	2024 Q2
3/31/2024	0.38	0.43 (14.87 %)	2024 Q1
12/31/2023	0.29	0.29 (-1.97 %)	2023 Q4
9/30/2023	0.48	0.5 (5.55 %)	2023 Q3
6/30/2023	0.36	0.39 (7.51 %)	2023 Q2
3/31/2023	0.34	0.37 (8.63 %)	2023 Q1
12/31/2022	0.23	0.26 (13.61 %)	2022 Q4
9/30/2022	0.41	0.47 (14.45 %)	2022 Q3
6/30/2022	0.3	0.35 (16.5 %)	2022 Q2
3/31/2022	0.39	0.41 (4.62 %)	2022 Q1
12/31/2021	0.32	0.32 (1.36 %)	2021 Q4
9/30/2021	0.37	0.46 (22.52 %)	2021 Q3
6/30/2021	0.26	0.35 (35.83 %)	2021 Q2
3/31/2021	0.28	0.29 (3.71 %)	2021 Q1
12/31/2020	0.3	0.29 (-2.82 %)	2020 Q4
9/30/2020	0.39	0.45 (13.09 %)	2020 Q3
6/30/2020	0.26	0.24 (-8.22 %)	2020 Q2
3/31/2020	0.4	0.47 (18.15 %)	2020 Q1
12/31/2019	0.32	0.31 (-4.59 %)	2019 Q4
9/30/2019	0.43	0.48 (12.42 %)	2019 Q3
6/30/2019	0.32	0.38 (17.96 %)	2019 Q2
3/31/2019	0.33	0.38 (15.31 %)	2019 Q1
12/31/2018	0.35	0.39 (10.05 %)	2018 Q4
9/30/2018	0.43	0.44 (3.87 %)	2018 Q3
6/30/2018	0.34	0.35 (4.66 %)	2018 Q2
3/31/2018	0.31	0.31 (-1.51 %)	2018 Q1
12/31/2017	0.33	0.34 (1.64 %)	2017 Q4
9/30/2017	0.41	0.41 (-1.2 %)	2017 Q3
6/30/2017	0.34	0.34 (0.68 %)	2017 Q2
3/31/2017	0.32	0.31 (-1.97 %)	2017 Q1
12/31/2016	0.32	0.33 (1.29 %)	2016 Q4
9/30/2016	0.38	0.4 (5.04 %)	2016 Q3
6/30/2016	0.27	0.31 (13.3 %)	2016 Q2
3/31/2016	0.23	0.25 (7.24 %)	2016 Q1
12/31/2015	0.23	0.23 (-1.84 %)	2015 Q4
9/30/2015	0.25	0.29 (16.02 %)	2015 Q3
6/30/2015	0.21	0.22 (0.77 %)	2015 Q2
3/31/2015	0.22	0.22 (-3.24 %)	2015 Q1
12/31/2014	0.33	0.27 (-19.54 %)	2014 Q4
9/30/2014	0.31	0.35 (13.16 %)	2014 Q3
6/30/2014	0.27	0.24 (-14.03 %)	2014 Q2
3/31/2014	0.27	0.26 (-1.61 %)	2014 Q1
12/31/2013	0.4	0.38 (-5.35 %)	2013 Q4
9/30/2013	0.35	0.36 (3.04 %)	2013 Q3
6/30/2013	0.34	0.33 (-3.44 %)	2013 Q2
3/31/2013	0.32	0.33 (4.02 %)	2013 Q1
12/31/2012	0.4	0.4 (-0.43 %)	2012 Q4
9/30/2012	0.36	0.33 (-8.55 %)	2012 Q3
6/30/2012	0.35	0.33 (-7.38 %)	2012 Q2
3/31/2012	0.38	0.34 (-10.48 %)	2012 Q1
12/31/2011	0.37	0.37 (-1.7 %)	2011 Q4
9/30/2011	0.37	0.35 (-4.26 %)	2011 Q3
6/30/2011	0.33	0.31 (-5.44 %)	2011 Q2
3/31/2011	0.39	0.4 (1.85 %)	2011 Q1
12/31/2010	0.36	0.44 (20.69 %)	2010 Q4
9/30/2010	0.34	0.35 (3.61 %)	2010 Q3
6/30/2010	0.37	0.36 (-1.62 %)	2010 Q2
3/31/2010	0.38	0.38 (0.08 %)	2010 Q1
12/31/2009	0.42	0.44 (4.64 %)	2009 Q4
9/30/2009	0.37	0.35 (-4.85 %)	2009 Q3
6/30/2009	0.38	0.35 (-7.46 %)	2009 Q2
3/31/2009	0.36	0.33 (-8.96 %)	2009 Q1
12/31/2008	0.35	0.33 (-5.18 %)	2008 Q4
9/30/2008	0.31	0.31 (2.93 %)	2008 Q3
6/30/2008	0.32	0.31 (-4.41 %)	2008 Q2
3/31/2008	0.32	0.31 (-5.19 %)	2008 Q1
12/31/2007	0.3	0.3 (2.73 %)	2007 Q4
9/30/2007	0.31	0.3 (-5.01 %)	2007 Q3
6/30/2007	0.31	0.3 (-4.09 %)	2007 Q2
3/31/2007	0.33	0.34 (1.57 %)	2007 Q1
12/31/2006	0.28	0.26 (-6.38 %)	2006 Q4
9/30/2006	0.29	0.31 (5.7 %)	2006 Q3
6/30/2006	0.31	0.29 (-5.52 %)	2006 Q2
3/31/2006	0.3	0.33 (11.43 %)	2006 Q1
12/31/2005	0.24	0.25 (4.72 %)	2005 Q4
9/30/2005	0.25	0.27 (5.82 %)	2005 Q3
6/30/2005	0.25	0.25 (1.25 %)	2005 Q2
3/31/2005	0.23	0.26 (12.76 %)	2005 Q1
12/31/2004	0.22	0.21 (-4.72 %)	2004 Q4
9/30/2004	0.19	0.23 (23.03 %)	2004 Q3
6/30/2004	0.24	0.25 (6.06 %)	2004 Q2

%	Name	Stocks	Change	Date
5.61748 %	BlackRock Institutional Trust Company, N.A.	229,134,683	0	2/23/2024
3.49527 %	The Vanguard Group, Inc.	142,570,611	2,700,708	1/31/2024
2.43635 %	Dodge & Cox	99,377,874	0	2/23/2024
2.18002 %	Norges Bank Investment Management (NBIM)	88,922,262	-983,824	3/1/2024
1.44197 %	GlaxoSmithKline Plc ESOP	58,817,197	-21,061,538	12/31/2023
1.34133 %	Silchester International Investors, L.L.P.	54,712,303	-897,673	2/2/2024
1.30507 %	BlackRock Advisors (UK) Limited	53,233,298	-4,533,276	3/1/2024
1.27676 %	BlackRock Investment Management (UK) Ltd.	52,078,353	-297,771	3/1/2024
0.97564 %	Legal & General Investment Management Ltd.	39,795,816	-34,173	3/1/2024
0.94733 %	Wellington Management Company, LLP	38,641,266	-151,013	3/1/2024
0.89602 %	State Street Global Advisors (US)	36,548,201	50,915	3/1/2024
0.87563 %	Schroder Investment Management Ltd. (SIM)	35,716,730	210,590	3/1/2024
0.80488 %	Columbia Threadneedle Investments (UK)	32,830,937	-69,556	3/1/2024
0.71170 %	Franklin Mutual Advisers, LLC	29,029,929	237,478	1/31/2024
0.62431 %	Causeway Capital Management LLC	25,465,534	693,871	2/2/2024
0.62097 %	M&G Investment Management Ltd.	25,328,986	-1,220,411	3/1/2024
0.61650 %	Geode Capital Management, L.L.C.	25,146,950	480,289	2/2/2024
0.58381 %	Mondrian Investment Partners Ltd.	23,813,334	-200,832	2/2/2024
0.58358 %	Jupiter Asset Management Ltd.	23,804,039	159,281	2/2/2024
0.56416 %	Aviva Investors Global Services Limited	23,011,943	1,453,258	3/1/2024
0.48925 %	Artemis Investment Management LLP	19,956,339	3,286,831	2/2/2024
0.46605 %	Independent Franchise Partners LLP	19,010,040	348,131	2/2/2024
0.44699 %	Nuveen LLC	18,232,364	8,007,262	1/31/2024
0.40635 %	State Street Global Advisors (UK) Ltd.	16,575,033	-20,613	3/1/2024
0.40180 %	Schweizerische Nationalbank	16,389,382	-519,043	5/30/2023
0.37656 %	California Public Employees' Retirement System	15,359,705	46,692	1/31/2024
0.36833 %	Credit Suisse Funds AG	15,023,853	1,119,875	5/30/2023
0.36262 %	Liontrust Investment Partners LLP	14,790,958	-1,249,477	1/31/2024
0.34690 %	GLG Partners LP	14,150,045	255,975	2/2/2024
0.32472 %	UBS Asset Management (UK) Ltd.	13,245,181	0	2/2/2024
0.29139 %	J O Hambro Capital Management Limited	11,885,811	-1,667,571	2/2/2024
0.29053 %	Baillie Gifford & Co.	11,850,550	4,228,141	1/31/2024
0.27964 %	Royal London Asset Management Ltd.	11,406,563	-706,900	3/1/2024
0.27131 %	Charles Schwab Investment Management, Inc.	11,066,504	81,848	1/31/2024
0.26256 %	Northern Trust Investments, Inc.	10,709,571	94,023	2/2/2024
0.23838 %	Allianz Global Investors GmbH	9,723,531	0	3/1/2024
0.23084 %	National Pension Service	9,415,939	205,258	1/31/2024
0.23064 %	LSV Asset Management	9,407,776	406,700	2/2/2024
0.21965 %	HSBC Global Asset Management (UK) Limited	8,959,611	-31,747	3/1/2024
0.21418 %	Capital Research Global Investors	8,736,332	-219,600	1/31/2024
0.21269 %	Legal & General Investment Management Japan KK	8,675,593	-177,842	1/31/2024
0.21126 %	Evenlode Investment Management Limited	8,617,138	-1,209,725	2/2/2024
0.20808 %	Arrowstreet Capital, Limited Partnership	8,487,372	0	2/2/2024
0.20781 %	Fidelity International	8,476,565	0	3/1/2024
0.19682 %	Caisse de Depot et Placement du Quebec	8,028,198	1,440,724	3/1/2024
0.19277 %	The National Farmers Union Mutual Insurance Society Limited	7,863,002	146,000	1/31/2024
0.18896 %	Schroder Investment Management North America Inc.	7,707,524	545,251	1/31/2024
0.18346 %	Aegon Asset Management Ltd	7,483,147	0	3/1/2024
0.18311 %	Aberdeen Asset Investments Limited	7,468,869	-148,960	3/1/2024
0.18075 %	AllianceBernstein L.P.	7,372,746	5,562,480	1/31/2024
0.17172 %	GIC Private Limited	7,004,430	81,623	3/1/2024
0.17058 %	Newton Investment Management Ltd.	6,957,834	3,307,800	1/31/2024
0.16996 %	Redwheel	6,932,551	950,096	2/2/2024
0.16843 %	DZ PRIVATBANK S.A.	6,869,990	512,641	2/1/2024
0.15962 %	JPMorgan Asset Management U.K. Limited	6,510,831	-62,173	2/2/2024
0.15272 %	BlackRock Japan Co., Ltd.	6,229,377	-390,925	1/31/2024
0.14695 %	Franklin Templeton Fund Management Limited	5,994,000	-65,000	1/31/2024
0.14623 %	Invesco Advisers, Inc.	5,964,558	-30,682	2/29/2024
0.14598 %	Commerzbank AG	5,954,413	-48,031	1/31/2024
0.13253 %	INVESCO Asset Management Limited	5,405,957	219,252	1/31/2024
0.12616 %	Sjunde AP-fonden	5,145,929	113,302	3/1/2024
0.12432 %	ReAssure Limited	5,070,813	-12,929	1/31/2024
0.12069 %	State Street Global Advisors (Japan) Co., Ltd.	4,922,877	-34,789	1/31/2024
0.11718 %	Bestinver Gestión S.A., S.G.I.I.C.	4,779,661	76,388	12/31/2023
0.11656 %	Landesbank Baden-Württemberg	4,754,310	449,901	1/31/2024
0.11542 %	Florida State Board of Administration	4,707,923	-685,703	9/30/2022
0.11435 %	Ariel Investments, LLC	4,664,293	-3,279,856	2/2/2024
0.11340 %	Altrinsic Global Advisors, LLC	4,625,572	-12,063	2/2/2024
0.11297 %	Brandes Investment Partners, L.P.	4,608,160	0	2/2/2024
0.11274 %	Wesleyan Assurance Society	4,598,417	-70,000	3/1/2024
0.11008 %	Goldman Sachs International	4,490,205	4,490,205	8/28/2023
0.10954 %	Barclays Wealth	4,468,121	-8,603	1/31/2024
0.10942 %	Scottish Friendly Asset Managers Limited	4,463,148	-8,639	1/31/2024
0.10837 %	Lazard Asset Management, L.L.C.	4,420,452	-59,015	3/1/2024
0.10625 %	Northern Trust Global Investments	4,333,875	48,792	2/2/2024
0.10588 %	BlackRock Asset Management Deutschland AG	4,318,747	0	3/1/2024
0.10499 %	DWS Investment GmbH	4,282,482	3,469	3/1/2024
0.09598 %	Pictet Asset Management Ltd.	3,914,790	305,218	12/31/2023
0.09560 %	Zürcher Kantonalbank (Asset Management)	3,899,346	-1,085,479	5/30/2023
0.09545 %	Santander Asset Management UK Limited	3,893,261	-349,340	2/29/2024
0.09468 %	Hargreaves Lansdown Fund Managers Ltd.	3,861,981	-1,191	3/31/2024
0.09086 %	Dimensional Fund Advisors, L.P.	3,706,215	194,965	2/1/2024
0.08816 %	APG Asset Management N.V.	3,596,064	412,304	1/31/2024
0.08805 %	State Street Global Advisors Ireland Limited	3,591,693	345,122	1/31/2024
0.08778 %	Sumitomo Mitsui Trust Asset Management Co., Ltd.	3,580,593	26,069	1/31/2024
0.08689 %	Bank Vontobel AG (Private Banking)	3,544,106	2,402,089	5/30/2023
0.08645 %	Mellon Investments Corporation	3,526,094	-2,434,847	1/31/2024
0.08601 %	State Street Global Advisors Australia Ltd.	3,508,225	-114,821	1/31/2024
0.08487 %	Thompson, Siegel & Walmsley LLC	3,461,694	-820,748	1/31/2024
0.08385 %	Aristotle Capital Management, LLC	3,420,296	85,420	12/31/2023
0.08358 %	Virgin Money Unit Trust Managers Ltd.	3,409,143	3,409,143	9/30/2022
0.08133 %	Vanguard Global Advisers LLC	3,317,363	117,072	3/31/2024
0.08047 %	Janus Henderson Investors	3,282,344	0	3/1/2024
0.07884 %	abrdn Investments Limited	3,215,902	-18,700	1/31/2024
0.07853 %	Putnam Investment Management, L.L.C.	3,203,050	2,892,112	3/31/2024
0.07779 %	UBS Asset Management (Switzerland)	3,172,851	-85,420	2/29/2024
0.07671 %	Amundi Deutschland GmbH	3,128,998	571,461	2/29/2024
0.07533 %	SEI Investments Management Corporation	3,072,684	-23,677	3/31/2024
0.07304 %	Storebrand Kapitalforvaltning AS	2,979,074	21,019	2/29/2024
0.07288 %	MFS Institutional Advisors, Inc	2,972,810	664,950	2/29/2024

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Farmacias Benavides B	SupplierCustomer	-	0,31	-	-	-	-
Aukett Swanke Group	SupplierCustomer	-	-0,04	-0,95	-0,83	-0,28	0,38
Eli Lilly	SupplierCustomer	0,79	0,45	0,76	0,63	0,77	0,53
Talend SA	SupplierCustomer	0,72	0,08	0,90	0,35	0,84	-
Shionogi	SupplierCustomer	0,72	0,28	-0,56	-0,53	0,35	0,64
Roivant Sciences	SupplierCustomer	0,70	0,75	-0,86	-0,56	-0,67	-
IWG	SupplierCustomer	0,69	0,63	-0,38	-0,46	-0,71	-0,77
Royalty Pharma A	SupplierCustomer	0,67	0,74	0,70	0,69	0,40	-0,29
Innovid	SupplierCustomer	0,65	0,73	-0,41	-0,22	-0,78	-
Sosei Group	SupplierCustomer	0,64	0,67	-0,54	-0,50	-0,61	-0,42

What values and corporate philosophy does GlaxoSmithKline represent?

GlaxoSmithKline PLC represents a values-driven corporate philosophy focused on improving people's health and well-being. The company prioritizes innovation, research, and development to deliver high-quality pharmaceutical and healthcare products. GlaxoSmithKline PLC is committed to ethical business practices, maintaining strong corporate governance, and promoting sustainability. With a strong emphasis on patient-centricity, the company seeks to address unmet medical needs and make a positive impact on global healthcare. GlaxoSmithKline PLC's dedication to scientific excellence, collaboration, and integrity drives its mission to help individuals live healthier and longer lives.

In which countries and regions is GlaxoSmithKline primarily present?

GlaxoSmithKline PLC is primarily present in various countries and regions across the globe. It has a significant presence in the United Kingdom, where the company was founded and has its headquarters. Moreover, GlaxoSmithKline PLC operates in multiple countries including the United States, India, China, Japan, Germany, France, Brazil, and many others. With a global footprint, GlaxoSmithKline PLC aims to provide its pharmaceutical, healthcare, and consumer products to a wide range of markets, ensuring the availability of its offerings to diverse populations worldwide.

What significant milestones has the company GlaxoSmithKline achieved?

GlaxoSmithKline PLC has achieved several significant milestones. The company successfully developed and launched several blockbuster drugs, such as Advair, Augmentin, and Ventolin, which have gained global recognition and contributed significantly to their revenue. GlaxoSmithKline PLC also embarked on strategic collaborations and acquisitions to expand their portfolio and strengthen their position in the pharmaceutical industry. Notably, the company established a joint venture with Pfizer to create a world-leading consumer healthcare business. Furthermore, GlaxoSmithKline PLC actively engages in research and development, continuously striving to bring innovative medicines and vaccines to patients worldwide. These achievements solidify GlaxoSmithKline PLC's reputation as a leading pharmaceutical company in the market.

What is the history and background of the company GlaxoSmithKline?

GlaxoSmithKline PLC, a renowned pharmaceutical company based in the United Kingdom, has a rich history and influential background. Established in 2000 through a merger of Glaxo Wellcome and SmithKline Beecham, the company has a heritage dating back to the 1800s. GlaxoSmithKline PLC is devoted to improving the quality of human life by developing and providing innovative medicines, vaccines, and healthcare products. Their mission is to help people do more, feel better, and live longer. With a focus on scientific excellence, ethical behavior, and patient-centric approach, GlaxoSmithKline PLC remains a global leader in the pharmaceutical industry while serving millions of individuals worldwide.

Who are the main competitors of GlaxoSmithKline in the market?

The main competitors of GlaxoSmithKline PLC in the market include pharmaceutical companies such as Pfizer Inc., Johnson & Johnson, Novartis AG, and Merck & Co., Inc.

In which industries is GlaxoSmithKline primarily active?

GlaxoSmithKline PLC is primarily active in the pharmaceutical industry.

What is the business model of GlaxoSmithKline?

The business model of GlaxoSmithKline PLC focuses on the development, manufacturing, and marketing of innovative pharmaceutical products, vaccines, and consumer healthcare goods. As one of the leading global healthcare companies, GlaxoSmithKline PLC aims to improve the overall quality of human life by addressing key medical challenges. They invest heavily in research and development to discover and deliver effective treatments for various diseases, including respiratory, infectious, and rare diseases. Additionally, the company also offers consumer healthcare products for general wellness. GlaxoSmithKline PLC continually seeks partnerships and collaborations to enhance their portfolio and ensure a sustainable business model.

What is the P/E ratio of GlaxoSmithKline 2024?

The GlaxoSmithKline P/E ratio is 10.12.

What is the P/S ratio of GlaxoSmithKline 2024?

The GlaxoSmithKline P/S ratio is 2.08.

What is the AlleAktien quality score of GlaxoSmithKline?

The AlleAktien quality score for GlaxoSmithKline is 7/10.

What is the revenue of GlaxoSmithKline 2024?

The expected GlaxoSmithKline revenue is 32.61 B GBP.

How high is the profit of GlaxoSmithKline 2024?

The expected GlaxoSmithKline profit is 6.71 B GBP.

What is the business model of GlaxoSmithKline

GlaxoSmithKline PLC (GSK) is a global company operating in the pharmaceutical, vaccines, and consumer healthcare sectors. The company operates in over 150 countries and employs over 100,000 people worldwide. In the pharmaceutical sector, GSK specializes in developing, manufacturing, and distributing medications. Key therapeutic areas include respiratory diseases, HIV/AIDS, oncology, vaccines, dermatology, and immunology. Some of GSK's well-known products are Advair, Lovaza, Zofran, Augmentin, and Lamictal. In the vaccines sector, GSK has a strong presence in the global market and offers both prophylactic and therapeutic vaccines. The company has a variety of vaccines against life-threatening diseases in its portfolio, including hepatitis A and B, HPV, Haemophilus influenzae type B, measles, mumps, rubella, and varicella. Consumer healthcare is another important business area for GSK, including products such as OTC medications, wellness products, and brands like Sensodyne, Aquafresh, Panadol, and Voltaren. In 2019, GSK merged its consumer healthcare division with Pfizer into a joint venture called GSK Consumer Healthcare. GSK's business model is based on a comprehensive research and development strategy aimed at developing innovative medications and vaccines that can improve and save lives. The company works closely with academics, researchers, and other partners. By partnering and collaborating with other companies and organizations, the company can leverage its resources and harness the potential of new technologies and developments. Additionally, GSK has a strong presence in international markets with a focus on emerging markets. The company relies on a diversified product range and a comprehensive portfolio of medications and vaccines to support long-term growth and sustainable development. The company also has an extensive pipeline of medications and vaccines in various stages of development. In summary, GSK is a globally operating company in the pharmaceutical, vaccines, and consumer healthcare sectors. Its business model is based on a comprehensive research and development strategy aimed at developing innovative medications and vaccines that can improve and save lives. The company has a strong presence in international markets and relies on a diversified portfolio of medications and vaccines to support long-term growth and sustainable development.

What is the GlaxoSmithKline dividend?

GlaxoSmithKline pays a dividend of 0.67 GBP distributed over 4 payouts per year.

How often does GlaxoSmithKline pay dividends?

GlaxoSmithKline pays out a dividend 4 times a year.

What is the GlaxoSmithKline ISIN?

The ISIN of GlaxoSmithKline is GB0009252882.

What is the GlaxoSmithKline WKN?

The WKN of GlaxoSmithKline is 940561.

What is the GlaxoSmithKline ticker?

The ticker of GlaxoSmithKline is GSK.L.

How much dividend does GlaxoSmithKline pay?

Over the past 12 months, GlaxoSmithKline paid a dividend of 0.56 GBP . This corresponds to a dividend yield of about 3.38 %. For the coming 12 months, GlaxoSmithKline is expected to pay a dividend of 1.04 GBP.

What is the dividend yield of GlaxoSmithKline?

The current dividend yield of GlaxoSmithKline is 3.38 %.

When does GlaxoSmithKline pay dividends?

GlaxoSmithKline pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of GlaxoSmithKline?

GlaxoSmithKline paid dividends every year for the past 26 years.

What is the dividend of GlaxoSmithKline?

For the upcoming 12 months, dividends amounting to 1.04 GBP are expected. This corresponds to a dividend yield of 6.31 %.

In which sector is GlaxoSmithKline located?

GlaxoSmithKline is assigned to the 'Health' sector.

Wann musste ich die Aktien von GlaxoSmithKline kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GlaxoSmithKline from 10/10/2024 amounting to 0.15 GBP, you needed to have the stock in your portfolio before the ex-date on 8/15/2024.

When did GlaxoSmithKline pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of GlaxoSmithKline in the year 2023?

In the year 2023, GlaxoSmithKline distributed 0.67 GBP as dividends.

In which currency does GlaxoSmithKline pay out the dividend?

The dividends of GlaxoSmithKline are distributed in GBP.

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e
1.2	1.41	1.35	1.7	2.03	2.55	3.13	3.4	4.1	4.93	5.66	2.85	7.64	8.34	7.98	7.98	8.49	18.08	20.49	21.21	21.44	20.36	21.66	23.23	22.72	24.35	28.37	28.39	27.39	26.43	26.51	23.01	23.92	27.89	30.19	30.82	33.75	24.35	24.7	29.32	30.33	32.61	34.49	36.48	38.64	39.05	39.33
-	17.67	-4.39	25.93	19.18	25.67	22.86	8.60	20.58	20.36	14.73	-49.58	167.81	9.20	-4.33	0.04	6.35	112.94	13.33	3.53	1.08	-5.05	6.39	7.23	-2.19	7.20	16.49	0.08	-3.54	-3.49	0.28	-13.20	3.99	16.58	8.24	2.10	9.52	-27.85	1.40	18.74	3.42	7.53	5.77	5.77	5.90	1.07	0.72
100.00	100.00	74.96	79.12	80.21	81.23	81.55	82.63	82.32	82.27	82.25	82.71	75.50	82.45	81.54	80.65	77.66	78.09	76.90	80.00	80.47	78.83	78.01	78.43	76.59	76.28	74.99	73.92	73.49	71.79	69.82	69.41	66.38	68.09	69.13	68.94	69.88	69.94	67.58	71.13	72.42	-	-	-	-	-	-
1.2	1.41	1.01	1.35	1.63	2.07	2.55	2.81	3.37	4.06	4.65	2.36	5.77	6.88	6.51	6.44	6.59	14.12	15.76	16.97	17.25	16.05	16.9	18.22	17.4	18.58	21.27	20.99	20.13	18.98	18.51	15.97	15.88	18.99	20.87	21.25	23.59	17.03	16.69	20.86	21.97	0	0	0	0	0	0
0.24	0.36	0.44	0.65	0.73	0.81	0.99	1.09	1.29	1.53	1.82	1.01	1.4	3.13	2.82	2.68	2.49	4.44	4.61	6.58	6.79	6.09	6.6	7.62	7.36	8.04	8.82	4.96	8.18	7.88	7.2	5.48	4.97	7.04	7.99	8.36	8.88	5.99	5.75	8.4	8.3	8.84	9.9	10.98	12.35	12.46	0
19.58	25.57	32.44	38.47	36.08	31.66	31.62	32.03	31.42	30.93	32.13	35.52	18.29	37.55	35.36	33.61	29.27	24.56	22.48	31.03	31.65	29.91	30.47	32.83	32.39	33.01	31.08	17.46	29.85	29.82	27.16	23.82	20.76	25.26	26.46	27.13	26.32	24.61	23.28	28.63	27.38	27.10	28.71	30.10	31.96	31.90	-
0.17	0.28	0.4	0.5	0.57	0.64	0.81	0.88	1.03	1.21	1.3	0.74	0.72	2	1.85	1.84	1.81	4.15	3.06	3.92	4.48	4.3	4.69	5.39	5.21	4.6	5.53	1.63	5.26	4.57	5.44	2.76	8.42	0.91	1.53	3.62	4.65	5.75	4.39	14.96	4.93	6.71	7.38	8.2	9.08	9.25	8.72
-	65.68	42.86	24.00	15.12	12.78	25.31	9.17	17.25	16.84	7.62	-42.96	-3.24	178.52	-7.36	-0.76	-1.36	129.38	-26.36	27.98	14.53	-4.06	9.00	14.93	-3.25	-11.74	20.19	-70.46	221.97	-13.23	19.08	-49.30	205.59	-89.17	67.98	136.49	28.21	23.77	-23.73	241.07	-67.05	36.12	10.08	11.00	10.83	1.86	-5.73
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2.69	2.69	2.69	2.96	2.96	2.98	3	3	3.01	3.02	3.04	3.05	3.39	3.57	3.62	6.18	3.64	6.13	6.12	5.93	5.82	5.75	5.72	5.7	5.57	5.23	5.11	5.13	5.1	4.99	4.92	4.87	4.89	3.93	3.95	3.98	4.01	4.03	4.05	4.08	4.11	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.22	0.38	0.59	0.94	1.17	1.29	1.59	2.13	1.75	2.5	2.76	3.19	1.27	1.26	1.66	1.89	1.97	3.59	2.32	2.47	3.62	4.13	5.23	3.04	4.53	6.01	6.81	6.24	5.9	4.27	5.6	4.41	5.91	4.99	3.91	3.96	4.79	6.37	4.34	7.88	4.99
0.27	0.28	0.35	0.3	0.34	0.42	0.53	0.67	0.72	0.92	0.91	0.97	2.05	2.12	1.34	1.61	1.68	3.34	3.63	3.52	3.72	3.79	4.41	4.36	4.65	5.33	5.49	4.73	4.44	4.12	3.97	3.56	3.88	4.68	4.69	5.19	5.49	5.56	6.26	5.47	5.98
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.44	0.48	0.57	0.98	0.9	0.86	1.04	0.97	0.89	0.84	0.67	0.71	0.76	0.86	0.88	0.95	1.32	0.89	1.61	1.24	1.26	1.14	1.65	1.7	1.77	1.64	1.43
0.27	0.25	0.28	0.29	0.31	0.35	0.42	0.49	0.48	0.6	0.58	0.58	0.81	0.8	0.86	1.15	1.54	2.28	2.09	2.08	2.11	2.19	2.18	2.44	3.06	4.06	4.06	3.84	3.87	3.97	3.9	4.23	4.72	5.1	5.56	5.48	5.95	6	5.78	5.15	5.5
0.03	0.04	0	0.14	0.16	0.22	0.33	0.36	0.37	0.43	0.4	0.5	0.15	0.18	0.51	0.37	0.33	1.09	1.07	1.82	2.14	2.55	0.47	0.32	0.72	1.15	0.45	0.37	1.08	0.4	0.45	1.59	0.48	0.71	0.49	1.17	1.61	0.62	0.53	0.63	0.75
0.78	0.95	1.22	1.66	1.99	2.28	2.86	3.65	3.31	4.44	4.65	5.23	4.28	4.37	4.8	5.51	6.08	11.27	10	10.75	12.63	13.63	13.18	10.99	13.63	17.27	17.57	16.04	16.17	13.69	15.23	14.68	16.59	16.71	15.91	16.93	19.49	20.25	18.67	20.77	18.64
0.35	0.41	0.54	0.65	0.83	1.12	1.61	2.08	2.34	2.96	3.18	3.21	4.17	3.85	3.58	3.63	3.72	6.64	6.85	6.65	6.44	6.47	6.65	6.93	7.82	9.68	9.37	9.05	8.75	8.78	8.87	9.05	9.67	10.81	10.86	11.06	11.31	11.01	10.67	9.62	9.96
0.04	0.04	0.05	0.05	0.05	0.06	0.02	0.03	0.03	0.06	0.06	0.05	0.1	0.09	0.05	0.1	0.48	2.54	3.23	3.12	3.07	0.33	0.64	0.74	0.85	1.03	1.35	1.79	1.15	1.37	1.53	1.45	1.46	1.25	1.1	1.56	2.15	3.42	2.21	1.54	1.19
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	432	540	560	533	505	558	559	642	732	886	875	816	893	858	935	965	950
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.97	1.67	1.64	1.7	2	3.38	3.29	4.46	5.87	8.18	8.53	7.8	10.16	9.28	8.32	16.67	18.78	17.56	17.2	30.96	29.82	30.08	14.32	14.77
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.11	0.14	0.17	0.17	0.17	0.14	0.14	0.7	0.76	1.37	2.1	3.36	3.61	3.75	4.36	4.21	3.72	5.16	5.97	5.73	5.79	10.56	10.6	10.55	7.05	6.81
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.65	2.84	2.45	2.91	2.47	2.69	2.95	2.56	2.42	2.78	3.16	4.69	4.34	4.72	4.33	4.48	5.98	5.89	6.68
0.39	0.46	0.58	0.7	0.88	1.19	1.63	2.11	2.37	3.02	3.24	3.26	4.26	3.95	3.64	3.84	4.35	10.32	11.92	11.58	11.35	8.95	14.02	14.56	17.38	22.12	25.29	26.19	24.91	27.78	26.86	25.97	36.86	42.37	40.47	41.14	60.2	60.18	60.43	39.38	40.36
1.17	1.4	1.8	2.36	2.87	3.47	4.49	5.75	5.68	7.46	7.89	8.49	8.54	8.31	8.44	9.35	10.43	21.59	21.92	22.33	23.98	22.58	27.2	25.55	31	39.39	42.86	42.23	41.08	41.48	42.09	40.65	53.45	59.08	56.38	58.07	79.69	80.43	79.1	60.15	59.01

0.18	0.19	0.37	0.37	0.37	0.37	0.75	0.75	0.75	0.76	0.76	0.76	0.88	0.89	0.89	0.91	0.91	1.56	1.54	1.51	1.49	1.48	1.49	1.5	1.5	1.42	1.42	1.42	1.39	1.35	1.34	1.34	1.34	1.34	1.34	1.35	1.35	1.35	1.35	1.35	1.35
0.02	0.03	0	0	0	0.04	0.01	0.04	0.08	0.15	0.23	0.26	0.37	0.62	0.81	1.15	1.25	0.03	0.17	0.22	0.26	0.3	0.55	0.86	1.27	1.33	1.37	1.43	1.67	2.02	2.6	2.76	2.83	2.95	3.02	3.09	3.17	3.28	3.3	3.44	3.45
0.47	0.64	0.72	1.08	1.41	1.88	1.98	2.43	2.74	3.64	4.05	4.44	-1.16	-0.28	0.14	0.65	0.98	6.13	5.8	4.85	5.97	4.14	5.27	7.03	6.83	6.65	8.34	6.8	5.4	2.74	3.02	0.06	0.73	-3.26	-4.35	-0.01	6.66	8.88	10.07	6.49	9.37
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1,448	-1,144	-849	-498	-401	-368	-164	-84	-289	-411	-208	-183	-226	-49	-373	-310
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.01	0.02	0.09	0.07	0.11	0.41	0.27	0.3	0.38	0.33	0.14	0.41	1.3	0.38	-0.31	-0.51
0.68	0.85	1.09	1.45	1.78	2.29	2.73	3.22	3.57	4.55	5.04	5.47	0.09	1.23	1.84	2.7	3.14	7.71	7.52	6.58	7.72	5.93	7.31	9.39	9.6	7.93	10.01	8.89	8.03	5.81	7	4.26	5.11	1.12	-0.07	4.36	11.41	14.59	15.06	10.6	13.35
0.41	0.43	0.56	0.27	0.32	0.39	0.48	0.57	0.61	0.81	0.8	0.76	1.27	1.28	0.3	0.29	0.37	0.81	0.76	0.72	0.69	0.71	0.82	0.87	0.93	1.15	1.86	2.14	2.57	2.67	2.74	2.79	3.12	3.6	3.53	3.65	4.14	4.36	4.54	3.87	3.72
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.66	0.7	0.71	2.22	3.27	3.37	3.23	3.22	3.88	3.65	3.67	4.59	4.48	4.38	4.45	4.35	4.51	4.7	5.32	6.44	6.93	8.54	9.11	9.75	11.19	10.59	10.71
0	0	0	0.24	0.29	0.33	0.51	0.59	0.6	0.79	0.93	0.68	1.19	1.33	1.75	1.83	1.94	3.77	3.28	3.17	3.23	3.21	3.62	2.03	2.24	3.32	4.31	5.98	5.3	3.17	3.64	2.86	3.67	4.83	13.29	4.52	3.88	4.31	4.35	4.41	3.83
0	0	0	0.2	0.25	0.14	0.43	0.87	0.37	0.6	0.4	0.72	3	1.55	0.59	0.98	1.09	1.6	1.27	1.28	0.84	0.83	1.2	0.72	2.06	0	0	0	0	0	1.84	2.92	0.44	1.43	0.77	4.42	5.02	1.15	0.8	1.64	1.01
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.59	0.34	1.16	0.68	0.86	0.27	0.62	0.75	0	0	1.44	0.96	1.47	0.29	2.7	3.63	0.95	0.03	0.87	2.7	2.06	1.37	1.9	2.58	2.8	2.31	1.81
0.41	0.43	0.56	0.71	0.87	0.86	1.41	2.03	1.57	2.2	2.13	2.16	5.47	4.15	3.89	4.15	5.26	9.08	9.43	8.81	8.6	8.72	9.51	7.27	10.35	10.02	12.12	12.79	15.01	13.82	13.68	13.3	13.42	19	26.57	22.49	24.05	22.15	23.67	22.81	21.07
0	0	0	0.01	0.01	0.03	0.04	0.14	0.14	0.21	0.27	0.25	1.47	1.7	1.84	1.8	1.26	1.75	2.11	3.09	3.65	4.38	5.27	4.77	7.07	15.23	14.79	14.81	12.2	14.67	15.46	15.84	15.32	14.66	14.26	20.27	23.59	23.43	20.57	17.04	15.21
0	0	0	0.03	0	0.05	0.08	0.14	0.18	0.19	0.14	0.15	0.03	0	0.05	0.06	0.07	0.04	0	0.74	0.61	0	0.57	0.6	0.89	0.71	0.65	0.71	0.82	1	0.69	0.45	1.52	1.93	1.4	1.16	3.81	3.6	3.56	0.29	0.31
0.09	0.12	0.15	0.16	0.2	0.23	0.23	0.23	0.23	0.31	0.3	0.46	1.49	1.24	0.77	0.57	0.65	1.76	2	2.3	2.66	3.27	4.28	3.27	2.79	5.11	4.57	4.18	4.22	5.24	4.45	6.13	14.31	18.52	10.66	10.48	9.89	10.45	9.96	9.92	9.63
0.09	0.12	0.15	0.2	0.21	0.32	0.35	0.51	0.54	0.71	0.71	0.86	2.98	2.94	2.66	2.43	1.97	3.55	4.11	6.13	6.91	7.65	10.12	8.64	10.75	21.06	20	19.69	17.24	20.91	20.6	22.42	31.15	35.12	26.32	31.9	37.29	37.48	34.09	27.24	25.14
0.49	0.55	0.71	0.91	1.08	1.18	1.76	2.54	2.11	2.91	2.84	3.02	8.45	7.09	6.55	6.58	7.23	12.64	13.54	14.94	15.51	16.38	19.63	15.91	21.09	31.08	32.12	32.49	32.25	34.73	34.27	35.72	44.57	54.12	52.89	54.39	61.34	59.62	57.76	50.05	46.21
1.17	1.4	1.8	2.36	2.87	3.47	4.49	5.75	5.68	7.46	7.89	8.49	8.54	8.31	8.39	9.28	10.38	20.35	21.06	21.52	23.23	22.3	26.94	25.29	30.7	39.01	42.13	41.37	40.29	40.54	41.27	39.98	49.68	55.24	52.82	58.75	72.74	74.21	72.82	60.65	59.56

1986	1987	1988	1989	1990	1991	1992	1993	null	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.51	0.58	0.64	1.04	1.1	1.29	1.53	1.82	1.82	1.01	2.58	3.13	2.82	2.68	2.63	5.3	4.73	5.55	6.39	6.09	6.87	7.81	5.31	4.71	5.67	1.85	5.46	4.74	5.63	2.83	8.37	1.06	2.17	4.05	5.27	6.39	5.1	4.92	5.31
0.06	0.07	0.09	0.12	0.15	0.19	0.23	0.28	0.28	0.14	0.39	0.41	0.37	0.36	0.37	0.77	0.81	0.84	0.86	0.89	0.9	0.96	1.02	1.23	1.56	1.68	1.42	1.45	1.41	1.48	1.63	1.77	1.92	1.86	2.33	2.35	2.38	2.15	2.29
23	5	30	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.05	-0.01	-0.08	-0.55	-0.66	-0.81	-0.82	-1.05	-1.05	-0.84	-0.23	-1.65	-1.27	-1.39	-1.07	-1.57	-1.04	-1.25	-2.54	-2.34	-2.01	-4.67	-2.86	-1.64	-1.9	0.88	-3.28	-4.09	-1.01	-0.35	-0.57	2.02	-0.15	1.18	-1.94	0.03	-0.77	-2.1	-2.83
0	-0	0.01	-0.01	0	-0.01	-0.01	-0	-0	0	0	-0.2	-0.23	-0.14	-0.11	-0.57	0.14	0.27	0.16	0.07	0.19	0.26	2.69	2.9	2.51	2.39	2.65	2.28	1.19	1.21	-6.86	1.64	2.98	1.34	2.36	-0.33	1.25	2.43	1.99
0	0	0	0	0	0	0	0	0	0	0	278	231	200	198	328	196	215	197	272	381	414	378	730	780	775	769	779	749	707	762	732	781	766	895	864	786	848	766
0.02	-0.03	-0.06	0.31	0.36	0.4	0.41	0.51	0.51	0.29	0.18	1.05	0.82	0.63	0.67	1.24	1.72	1.63	1.92	1.58	1.71	3.85	1.92	1.85	1.7	1.83	1.46	1.67	1.28	1.11	2.06	1.61	1.34	1.33	1.51	1.66	1.29	1.31	1.33
0.54	0.65	0.7	0.61	0.6	0.66	0.93	1.05	1.05	0.32	2.75	1.7	1.7	1.51	1.82	3.94	4.64	5.41	4.87	4.71	5.96	4.36	6.16	7.21	7.84	6.8	6.25	4.38	7.22	5.18	2.57	6.5	6.92	8.42	8.02	8.44	7.95	7.4	6.77
-193	-281	-382	-641	-616	-600	-608	-575	-575	-227	-457	-401	-415	-475	-597	-1,103	-1,311	-1,226	-1,062	-1,043	-1,181	-1,590	-2,143	-2,069	-1,873	-1,635	-1,328	-1,520	-1,701	-1,751	-1,901	-2,352	-2,202	-1,796	-2,163	-2,239	-2,931	-2,258	-2,344
-0.52	-0.47	-0.08	-0.81	-0.83	-0.37	-0.86	-1.36	-1.36	-0.63	-3.98	0.07	-0.54	-0.69	-0.9	-0.48	-1.44	-1.09	-2.28	-1.52	-1.66	-1.52	-3.01	-1.15	-4.01	-1.87	-0.11	-2.63	0.52	-1.08	6.04	-1.27	-1.44	-1.55	-5.35	2.16	-1.78	-8.77	-1.6
-0.33	-0.19	0.3	-0.17	-0.22	0.23	-0.25	-0.79	-0.79	-0.4	-3.52	0.47	-0.12	-0.22	-0.3	0.62	-0.13	0.14	-1.21	-0.47	-0.48	0.07	-0.87	0.92	-2.14	-0.23	1.22	-1.11	2.23	0.67	7.94	1.08	0.76	0.24	-3.19	4.4	1.15	-6.51	0.75
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.09	0.05	-0.1	0.08	0.45	-0.49	0.03	-0.01	-0.01	0.29	2.64	-0.87	-0.25	0.07	0.25	-0.68	-0	0.46	0.58	0.92	0.02	-0.77	4.87	2.42	1.21	-1.34	-0	3.58	0.01	0.23	-2.44	0.13	-0.99	8.12	3.52	-4.23	-2.21	-4.82	-2.57
1	0	38	21	20	24	69	51	51	18	88	215	184	284	104	185	-1,587	-2,164	-939	-1,424	-679	-881	-3,218	-3,635	56	79	-1,896	-2,079	-964	-166	-26	15	-9	74	51	29	21	25	10
-0.02	-0.1	-0.27	0.11	0.47	-0.47	0.1	0.04	0.04	0.31	1.74	-1.68	-1.27	-0.9	-0.96	-2.63	-3.81	-3.91	-2.62	-3.02	-2.91	-4.79	-1.74	-4.91	-2.77	-5.57	-6.23	-3.35	-6.27	-5.39	-7.1	-6.39	-6.38	-6.39	-1.84	-10.13	-7.59	0.82	-5.64
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.05	0.14	0.14	0.08	-0.04	0.14	-0.54	-0.6	-0.76	-1.04	-1.11	-0.93	-1.04	-1.64	-1.6	-0.77	-1.69	-1.48	-10.66	-1.45	-1.95	-1.4	9.09	-0.84
-112	-156	-207	0	0	0	0	0	0	0	-994	-1,020	-1,207	-1,255	-1,305	-2,084	-2,363	-2,347	-2,348	-2,477	-2,390	-2,598	-2,793	-2,929	-3,003	-3,205	-3,406	-3,814	-3,680	-3,843	-3,874	-4,850	-3,906	-3,927	-3,953	-3,977	-3,999	-3,467	-2,247
-0	0.03	0.41	-0.09	0.24	-0.18	0.17	-0.27	-0.27	0	0.51	0.09	-0.1	-0.08	-0.04	0.82	-0.61	0.41	-0.03	0.17	1.62	-2.21	1.46	2.25	0.9	-0.56	-0.2	-1.7	1.33	-1.2	1.46	-0.88	-1.01	0.49	0.74	0.43	-1.44	-0.39	-0.57
346	368	318	-30	-21	56	319	478	0	95	2,293	1,296	1,288	1,038	1,218	2,833	3,326	4,181	3,811	3,662	4,777	2,767	4,018	5,136	5,968	5,162	4,922	2,855	5,521	3,425	668	4,145	4,716	6,625	5,857	6,202	5,021	5,145	4,424
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Scope 1 - Direct Emissions	626,418
Scope 2 - Indirect emissions from purchased energy	264,677
Scope 3 - Indirect emissions within the value chain	—
Total CO₂ emissions	891,095
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	✅
Fur & Leather	❌
Pesticides	❌
Palm Oil	❌
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	✅
Environmentally friendly packaging	✅
Hazardous substances	✅
Fuel consumption and efficiency	❌
Water consumption and efficiency	✅

Percentage of female employees	47
Percentage of women in management	—
Percentage of Asian employees	13.3
Share of Asian management	16.5
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	2.7
Black Management Share	3.1
Percentage of white employees	80.7
White Management Share	76.8
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	✅
Privacy concept	—
Occupational health and safety	✅
Catholic	✅

Environmental reporting	✅
Stakeholder Engagement	✅
Call Back Policies	❌
Antitrust law	❌

Stock Exchange	GlaxoSmithKline Ticker
FRANKFURT	GS71.F
LONDON STOCK EXCHANGE	GSK.L
SIX	GSK.SW
XETRA	GS7.DE

GlaxoSmithKline Ticker	GlaxoSmithKline FIGI
GSKUSD:EO	BBG000H7K468
GSKUSD:E1	BBG000H7LMB1
GSK:EO	BBG000JFN189
GSK:XJ	BBG000JFN6C3
GSK:XS	BBG000JFNC03
GSK:E1	BBG000JFNDF5
GSKGBP:EO	BBG000JMXXZ3
GSKGBP:XJ	BBG000JMZ4B1
GSKGBP:XS	BBG000JMZ9W7
GSKGBP:E1	BBG000JMZBB5
GSKEUR:EO	BBG000JP5JD2
GSKEUR:XJ	BBG000JP5N16
GSKEUR:XS	BBG000JP5VB7
GSKEUR:E1	BBG000JP5XQ7
GSKPEN:EO	BBG000K4N949
GSKPEN:E1	BBG000K4NN84
GSKCAD:EO	BBG000KMD0C0
GSKCAD:E1	BBG000KMFGM2
GSKCHF:EO	BBG007F5TC08
GSKCHF:XJ	BBG007F5TC80
GSKCHF:XS	BBG007F5TCH0
GSKCHF:E1	BBG007F5TCK6
GSKUSD:XX	BBG00JN778Y5
GSK:XX	BBG00JN7FZC0
GSKGBP:XX	BBG00JN7JCC7
GSKEUR:XX	BBG00JN7KHV3
GSKPEN:XX	BBG00JN7NM30
GSKCAD:XX	BBG00JN7PQC9
GSKCHF:XX	BBG00JN89023
GSKGBP:T2	BBG00N0VMLR0
GSKGBP:WT	BBG00NRHBJC5
GS7:LA	BBG018H804Z8
GS7:LU	BBG018J1N7J7

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

TickerGSK.L

ISINGB0009252882

WKN940561

GlaxoSmithKline stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

GlaxoSmithKline Stock Price History

GlaxoSmithKline Revenue, EBIT, Net Income GB0009252882 · 940561

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

GlaxoSmithKline Revenue, EBIT and net profit per share

GlaxoSmithKline Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

GlaxoSmithKline stock margins GB0009252882 · 940561

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

GlaxoSmithKline Margin History

GlaxoSmithKline Stock Sales Revenue, EBIT, Earnings per Share GB0009252882 · 940561

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

GlaxoSmithKline Revenue, EBIT and net profit per share

GlaxoSmithKline business model

GlaxoSmithKline SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

GlaxoSmithKline Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

GlaxoSmithKline historical P/E ratio, EBIT, and P/S ratio.

GlaxoSmithKline shares outstanding GB0009252882 · 940561

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

GlaxoSmithKline Stock splits

GlaxoSmithKline dividend history and estimates GB0009252882 · 940561

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

GlaxoSmithKline Dividend History

GlaxoSmithKline dividend payout ratio GB0009252882 · 940561

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
GSK.L

ISIN
GB0009252882

WKN
940561